Source: Transfusion and Apheresis Science. Unidade: FM
Subjects: TRANSFUSÃO DE SANGUE (MORTALIDADE;COMPLICAÇÕES), LEUCÓCITOS, PULMÃO (LESÕES), ANTICORPOS, PLAQUETAS SANGUÍNEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLATYTA, Paula Fraiman et al. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil. Transfusion and Apheresis Science, v. 48, n. 1, p. 15-20, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.transci.2012.07.010. Acesso em: 09 maio 2024.APA
Blatyta, P. F., Liu, J., Mendrone-Junior, A., Wright, D. J., Leão, S. C., Lopes, M. I., et al. (2013). The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil. Transfusion and Apheresis Science, 48( 1), 15-20. doi:10.1016/j.transci.2012.07.010NLM
Blatyta PF, Liu J, Mendrone-Junior A, Wright DJ, Leão SC, Lopes MI, Carneiro-Proietti AB, Sabino EC, Almeida-Neto C de. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil [Internet]. Transfusion and Apheresis Science. 2013 ; 48( 1): 15-20.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.transci.2012.07.010Vancouver
Blatyta PF, Liu J, Mendrone-Junior A, Wright DJ, Leão SC, Lopes MI, Carneiro-Proietti AB, Sabino EC, Almeida-Neto C de. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil [Internet]. Transfusion and Apheresis Science. 2013 ; 48( 1): 15-20.[citado 2024 maio 09 ] Available from: https://doi.org/10.1016/j.transci.2012.07.010
